EYE.AX · NOVA EYE MEDICAL LIMITED
Australia · RS rating 81 · As of 2026-10-14
| Price | 0.14 AUD |
|---|---|
| 1-day change | +1.9% |
| RS rating (overall / 1M / 3M / 12M) | 81 / 81 / 80 / 53 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 42 / 27 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +30.8% |
| Market cap (USD) | $26.8M |